• 1
    Wegmann DR. The immune response to islets in experimental diabetes and insulin-dependent diabetes mellitus. Curr Opin Immunol 1996; 8:8604.
  • 2
    Homo-Delarche F & Boitard C. Autoimmune diabetes: the role of the islets of Langerhans. Immunol Today 1996; 17:45660.
  • 3
    Larger E, Becourt C, Bach JF, Boitard C. Pancreatic islet beta-cells drive T cell immune responses in the nonobese diabetic mouse model. J Exp Med 1995; 181:163542.
  • 4
    Nerup J, Mandrup-Poulsen T, Helqvist S et al. On the pathogenesis IDDM. Diabetologia 1994; 37 (Suppl. 2):S82S89.
  • 5
    Tiedge M, Lortz S, Drinkgern J, Lenzen S. Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells. Diabetes 1997; 46:173342.
  • 6
    Kubisch H-M, Wang J, Bray TM, Phillips JP. Targeted overexpression of Cu/Zn superoxide dismutase protects pancreatic beta-cells against oxidative stress. Diabetes 1997; 46:15636.
  • 7
    Burkart V, Wang Z-Q, Radons J et al. Mice lacking the poly (ADP-ribose) polymerase gene are resistant to pancreatic beta-cell destruction and diabetes development induced by streptozocin. Nature Med 1999; 5:31419.
  • 8
    Traverso N, Menini S, Cosso L et al. Immunological evidence for increased oxidative stress in diabetic rats. Diabetologia 1998; 41:26570.DOI: 10.1007/s001250050902
  • 9
    Festa A, Kopp HP, Schernthaner G, Menzel EJ. Autoantibodies to oxidised low density lipoproteins in IDDM are inversely related to metabolic control and microvascular complications. Diabetologia 1998; 41:3506.DOI: 10.1007/s001250050914
  • 10
    Griffin ME, McInerney D, FraSeries A et al. Autoantibodies to oxidised low density lipoprotein: the relationship to low density lipoprotein fatty acid composition in diabetes. Diabet Med 1997; 14:7417.
  • 11
    Casciola-Rosen L, Wigley F, Rosen A. Scleroderma autoantigens are uniquely fragmented by metal-catalyzed oxidation reactions: implications for pathogenesis. J Exp Med 1997; 185:719.
  • 12
    Loweth AC, Williams GT, Scarpello JHB, Morgan NG. Heterotrimeric G-proteins are implicated in the regulation of apoptosis in pancreatic beta-cells. Exp Cell Res 1996; 229:6976.
  • 13
    Davenport C, Lovell H, James RFL, Todd I. Brain-reactive antibodies in BB/d rats do not recognise glutamic acid decarboxylase. Clin Exp Immunol 1995; 101:12735.
  • 14
    Davenport C, Radford PM, Al-Bukhari TAMA et al. Heterogeneity in the occurrence of a subset of autoantibodies to glutamic acid decarboxylase in autoimmune polyendocrine patients with islet cell antibodies. Clin Exp Immunol 1998; 111:497505.DOI: 10.1046/j.1365-2249.1998.00526.x
  • 15
    Christgau S, Schierbeck H, Aanstoot HJ et al. Pancreatic β cells express two autoantigenic forms of glutamic acid decarboxylase, a 65 kD hydrophilic form and a 64kD amphiphilic form which can be both membrane bound and soluble. J Biol Chem 1991; 266:2125764.
  • 16
    Stadtman ER. Oxidation of free amino acids and amino acid residues in proteins by radiolysis and by metal-catalyzed reactions. Annu Rev Biochem 1993; 62:797821.
  • 17
    Baekkeskov S, Aanstoot HJ, Christgau S et al. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 1990; 347:1516.
  • 18
    Davies KJA & Delsignore ME. Protein damage and degradation by oxygen radicals. III. Modification of secondary and tertiary structure. J Biol Chem 1987; 262:990813.
  • 19
    Sheikh SN & Martin DL. Heteromers of glutamate decarboxylase isoforms occur in rat cerebellum. J Neurochem 1996; 66:208290.
  • 20
    Schwartz HL, Chandonia J-M, Kash SF et al. High-resolution autoreactive epitope mapping and structural modeling of the 65 kDa form of human glutamic acid decarboxylase. J Mol Biol 1999; 287:983999.DOI: 10.1006/jmbi.1999.2655
  • 21
    Rowley MJ, Chen QY, Teoh KL et al. Diabetic sera react with the glutamic acid decarboxylase molecule in a dimeric–oligomeric form. Clin Exp Immunol 1996; 106:3238.
  • 22
    Teoh KL, Fida S, Rowley MJ, MacKay IR. Autoantigenic reactivitiy of diabetes sera with a hybrid glutamic acid decarboxylase GAD67–65 molecule GAD67(1–101)/GAD(96–585). Autoimmunity 1998; 28:25966.
  • 23
    Daw K, Ujihara N, Atkinson M, Powers AC. Glutamic acid decarboxylase autoantibodies in stiff-man syndrome and insulin-dependent diabetes mellitus exhibit similarities and differences in epitope recognition. J Immunol 1996; 156:81825.
  • 24
    Rahier J, Loozen S, Goebbels RM, Abrahem M. The haemochromatotic human pancreas: a quantitative immunohistochemical and ultrastructural study. Diabetologia 1987; 30:512.
  • 25
    Saudek CD, Hemm RM, Peterson CM. Abnormal glucose tolerance in beta-thalassemia major. Metabolism 1977; 26:4352.
  • 26
    Neinhuis AW. Vitamin C and iron. N Engl J Med 1981; 304:1701.
  • 27
    Nomikos IN, Prowse SJ, Carotenuto P, Lafferty KJ. Combined treatment with nicotinamide and desferrioxamine prevents islet allograft destruction in NOD mice. Diabetes 1986; 35:13024.
  • 28
    Harrison PM & Hoare RJ. Metals in biochemistry. Chapman & Hall, London, 1980.
  • 29
    Samuni A, Chevion M, Czapski G. Unusual copper-induced sensitization of the biological damage due to superoxide radicals. J Biol Chem 1981; 256:126325.
  • 30
    Schroeder HA. Municipal drinking water and cardiovascular death rates. JAMA 1966; 195:815.
  • 31
    Parslow RC, McKinney PA, Law GR et al. Incidence of childhood diabetes mellitus in Yorkshire, northern England, is associated with nitrate in drinking water: an ecological analysis. Diabetologia 1997; 40:5506.DOI: 10.1007/s001250050714
  • 32
    Yoon J-W, Yoon C-S, Lim H-W et al. Control of autoimmune diabetes in NOD mice by GAD expression or suppression in beta cells. Science 1999; 284:11837.